| | EVALUATION OF AIRBORNE EXPOSURE-LIMITS FOR G-AGENTS: |
| | 1,34 | | MB | OCCUPATIONAL AND GENERAL POPULATION EXPOSURE CRITERIA |
| | 90 | | stron |
| | 2312 | | ID | U.S. Army Edgewood Chemical Biological Center |
| | 1999 | | rok |
| | CONTENTS |
| | 1. PURPOSE |
| | 2.1 Introduction |
| | 2.2 Chemical and Physical Properties |
| | 2.3 Biological Properties |
| | 2.3.1 Mechanism of Action |
| | 2.3.2 G-agent Vapor Intoxication: Local vs. Systemic Responses |
| | 2.3.3 Assessing the Severity of G-agent Intoxication. |
| | 2.3.4 Acute Toxic Effects of G-agents by Inhalation Exposure. |
| | 2.3.5 Central Nervous System (CNS) Effects |
| | 2.3.6 Delayed Neuropathy |
| | 2.3.7 Cardiac Complications |
| | 2.3.8 Mutagenicity, Carcinogenicity, Teratogenicity and Reproductive Toxicity |
| | 3. FINDINGS/DISCUSSION |
| | 3.1 Human Exposure Data |
| | 3.2 Developing Exposure Criteria: a Traditional Approach |
| | 3.3 Selecting the ‘Critical Adverse Effect(s)” for G-Agent Airborne Exposure Criteria |
| | 3.4 Derivation of Airborne Exposure bvels for GB: Considerations in Selecting a Critical Study |
| | 3.4.1 Calculating the AEL for Occupational Workers (Worker Population Limit or WPL) for GB Vapor |
| | |
| | 3.4.2 Calculating the AEL for General Population (General Population Limit or GPL) for GB Vapor |
| | 3.4.3 Summary of Airborne Exposure Levels for GB Vapor |
| | 3.5 Derivation of Airborne Exposure Levels for GA, GD, and GF |
| | 4. CONCLUSIONS |
| | 5. RECOMMENDATIONS |
| | LITERATURE CITED |
| | GLOSSARY |